Xinghai Wang

This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Micurx Pharmaceuticals, Inc., Merck Sharp + Dohme Corp., Shanghai Micro Electronics Equipment (Group) Co., Ltd.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinghai Wang. Retrieved from https://idiyas.com/inventor/xinghai-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 6)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Hayward, CA (US) (2017)
Shanghai, CN (2012 - 2021)

Company Filing History:

3 out of 4

Micurx Pharmaceuticals, Inc.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 94

Shanghai Micro Electronics Equipment (Group) Co., Ltd.

patents

4. 1 out of 1

Shanghai Micurx Pharmaceutical Co., Ltd.

patent

5. 1 out of 834,570

Other

patents

Years Active: 2012-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12180242 - Pharmaceutical crystal of contezolid acefosamil, preparation method therefor, and uses thereof (2024-12-31),

2. 10942063 - Apparatus and method for measuring amplitude of scanning reflector (2021-03-09),

3. 9771394 - Antimicrobial polymyxins for treatment of bacterial infections (2017-09-26),

4. 9382276 - Water-soluble O-carbonyl phosphoramidate prodrugs for therapeutic administration (2016-07-05),

5. 9090661 - Inhibitors of hepatitis C virus replication (2015-07-28),

6. 8530452 - Tricyclic boron compounds for antimicrobial therapy (2013-09-10),

7. 8232270 - Bivalent (−)-meptazinol compounds and/or their salts, and their preparation and futilization (2012-07-31),

Title: The Innovations of Xinghai Wang

Introduction

Xinghai Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals and optical technology. With a total of 7 patents, his work reflects a commitment to advancing scientific knowledge and practical applications.

Latest Patents

Wang's latest patents include a pharmaceutical crystal of contezolid acefosamil, which details a preparation method and its various uses. This invention focuses on a crystal or crystal complex of formula I, where R can be hydrogen, sodium, or a mixture thereof in any ratio. Another notable patent is an apparatus and method for measuring the amplitude of a scanning reflector. This device comprises a light source for outputting an optical signal, a diaphragm for modifying the light spot, and a photoelectric sensor with multiple sensing elements to detect and collect the reflected optical signal. This innovation allows for the characterization of scanning mirrors before their use, ensuring optimal performance.

Career Highlights

Throughout his career, Xinghai Wang has worked with notable companies such as Micurx Pharmaceuticals, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical development and optical technologies.

Collaborations

Wang has collaborated with esteemed colleagues, including Mikhail Fedorovich Gordeev and Jinqian Liu. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Xinghai Wang's contributions to the fields of pharmaceuticals and optical technology are noteworthy. His innovative patents and collaborations highlight his role as a significant inventor in his field.

Profile summary based on public USPTO records.